Diabetes in America

June 2024
Diabetes in America cover image

Diabetes in America is the NIDDK’s compilation and assessment of epidemiologic, public health, clinical research, and clinical trial data focused on diabetes, its complications and treatment, health care utilization, and diabetes prevention in the United States. These data are intended to be a valuable resource for the research community, clinicians, policy makers, and individuals with diabetes, as well as their caregivers and family members.

There have been three printed editions of Diabetes in America. It was first published in 1984; the second and third editions were published in 1995 and 2018, respectively. The third edition is also available on the National Center for Biotechnology Information, National Library of Medicine’s (NLM) Bookshelf, which expands access to the scientific community through its link to PubMed®

Diabetes in America has been migrated to an exclusively digital format. Each updated or new article will be available in this Report and on NLM’s Bookshelf. It will also be indexed in PubMed. This was done to remain dynamic as scientific knowledge related to diabetes advances.

Diabetes in America is organized into four broad topic areas. 

  • Section I: Spectrum of Diabetes. Provides descriptive epidemiology of diabetes in the United States based on national surveys and community-based studies, including prevalence estimates and incidence rates; sociodemographic, metabolic, and lifestyle characteristics; risk factors for developing diabetes; and unique aspects of diabetes in selected populations.
  • Section II: Complications of Diabetes and Related Conditions. Reviews the complications that affect people with diabetes, including mortality. 
  • Section III: Medical Care for Diabetes. Describes diabetes medication use and self-care practices, health care utilization, and quality of care; and economic aspects including health insurance and health care costs for people with diabetes.
  • Section IV: Prevention of Diabetes. Presents the results of clinical trials and other intervention studies that focus on the prevention of diabetes.

View Publication

Diabetes in America

Table of Contents

Jean M. Lawrence, ScD, MPH, MSSA, Sarah Stark Casagrande, PhD, William H. Herman, MD, Deborah J. Wexler, MD, and William T. Cefalu, MD.

Section I: Spectrum of Diabetes

Maria J. Redondo, MD, PhD, MPH, Suna Onengut-Gumuscu, PhD, and Kyle J. Gaulton, PhD 
PMID: 38117927

Raymond J. Kreienkamp, MD, PhD, Benjamin F. Voight, PhD, Anna L. Gloyn, DPhil, and Miriam S. Udler, MD, PhD
PMID: 38117926

Maria V. Salguero, MD, MSc, Marilyn Arosemena, MD, Toni Pollin, PhD, Siri Atma W. Greeley, MD, PhD, Rochelle N. Naylor, MD, Lisa Letourneau-Freiberg, MPH, RD, Tiana L. Bowden, Diane Wei, and Louis H. Philipson, MD, PhD
PMID: 38117925

Lars C. Stene, PhD, Jill M. Norris, MPH, PhD, and Marian Rewers, MD, PhD
PMID: 38117928

Section II: Complications of Diabetes and Related Conditions

Rita R. Kalyani, MD, MHS, Brendan M. Everett, MD, MPH, Leigh Perreault, MD, and Erin D. Michos, MD, MHS
PMID: 38117924

Section III: Medical Care for Diabetes

Sarah S. Casagrande, PhD, Joohyun Park, PhD, William H. Herman, MD, MPH, and Kai McKeever Bullard, PhD
PMID: 38117923

Amy E. Rothberg, MD, Jamy D. Ard, MD, Kimberly A. Gudzune, MD, MPH, and William H. Herman, MD, MPH
PMID: 38696642

Section IV: Prevention of Diabetes

Laura M. Jacobsen, MD, Desmond A. Schatz, MD, Kevan C. Herold, MD, and Jay S. Skyler, MD, MACP, FRCP
PMID: 38843373


Diabetes in America is in the public domain of the United States. You may use the work without restriction in the United States.

Related Reports